Cognitive Stimulation Therapy Group for Residential Home Residents With Dementia and Mild
The research aims to investigate the effectiveness a cognitive stimulation therapy group for older adults with dementia and mild cognitive impairment living in residential homes. This study adopts a multicenter randomized control trial two arms research design. The randomized controlled trial will compare a typical 14-
| Condition(s) | Cognitive Functions |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | The research aims to investigate the effectiveness a cognitive stimulation therapy group for older adults with dementia and mild cognitive impairment living in residential homes. This study adopts a multicenter randomized control trial two arms research design. The randomized controlled trial will compare a typical 14-session cognitive stimulation therapy group with a calligraphy group to determine whether the 14-session cognitive stimulation therapy group can produce better intervention outcomes for older adults with dementia and mild cognitive impairment, including cognitive functions, depressive symptoms, activities engagement, social functioning and, quality of life. |
| Who can participate | Inclusion Criteria: 1. age 60 years or older; 2. diagnosis of MCI or dementia according to the Diagnostic and Statistical Manual of Mental Disorder (Fifth edition, Text Revision). Remark: Participants who do not receive a diagnosis of MCI or dementia will undergo a screening assessment by a researcher using the Chinese Montreal Cognitive Assessment (MoCA)-5 minutes. Exclusion Criteria: Those who are unable to participate independently in group activities, who exhibit disruptive behavior and/or are severely impaired by physical disabilities (e.g. severe hearing and visual impairment) and physical illnesses (e.g. frequent hospital stays) are excluded. |
| Ages | 60 Years |
| Sex | All |
| Accepts healthy volunteers | Yes |
| Lead sponsor | City University of Hong Kong |
| Locations | Hong Kong, Hong Kong, Hong Kong |
| Start date | 2026-01-01 |
| NCT ID | NCT07372066 |
| Official listing | https://clinicaltrials.gov/study/NCT07372066 |